124 related articles for article (PubMed ID: 22741776)
1. Design of novel dihydroxynaphthoic acid inhibitors of Plasmodium falciparum lactate dehydrogenase.
Megnassan E; Keita M; Bieri C; Esmel A; Frecer V; Miertus S
Med Chem; 2012 Sep; 8(5):970-84. PubMed ID: 22741776
[TBL] [Abstract][Full Text] [Related]
2. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.
Choi SR; Pradhan A; Hammond NL; Chittiboyina AG; Tekwani BL; Avery MA
J Med Chem; 2007 Aug; 50(16):3841-50. PubMed ID: 17636950
[TBL] [Abstract][Full Text] [Related]
4. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
[TBL] [Abstract][Full Text] [Related]
5. Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
Choi SR; Beeler AB; Pradhan A; Watkins EB; Rimoldi JM; Tekwani B; Avery MA
J Comb Chem; 2007; 9(2):292-300. PubMed ID: 17316052
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase.
Vivas L; Easton A; Kendrick H; Cameron A; Lavandera JL; Barros D; de las Heras FG; Brady RL; Croft SL
Exp Parasitol; 2005 Oct; 111(2):105-14. PubMed ID: 16098967
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.
Deck LM; Royer RE; Chamblee BB; Hernandez VM; Malone RR; Torres JE; Hunsaker LA; Piper RC; Makler MT; Vander Jagt DL
J Med Chem; 1998 Sep; 41(20):3879-87. PubMed ID: 9748363
[TBL] [Abstract][Full Text] [Related]
8. Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and
Joshi N; Hada R; Gupta S; Khan J; Dobrowolski J; Dhar PK; Kumar N; Singh S
J Biomol Struct Dyn; 2022 Jul; 40(11):5159-5174. PubMed ID: 33416018
[TBL] [Abstract][Full Text] [Related]
9. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
10. Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity.
Cameron A; Read J; Tranter R; Winter VJ; Sessions RB; Brady RL; Vivas L; Easton A; Kendrick H; Croft SL; Barros D; Lavandera JL; Martin JJ; Risco F; García-Ochoa S; Gamo FJ; Sanz L; Leon L; Ruiz JR; Gabarró R; Mallo A; Gómez de las Heras F
J Biol Chem; 2004 Jul; 279(30):31429-39. PubMed ID: 15117937
[TBL] [Abstract][Full Text] [Related]
11. Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase.
Conners R; Schambach F; Read J; Cameron A; Sessions RB; Vivas L; Easton A; Croft SL; Brady RL
Mol Biochem Parasitol; 2005 Aug; 142(2):137-48. PubMed ID: 15978953
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
Penna-Coutinho J; Cortopassi WA; Oliveira AA; França TC; Krettli AU
PLoS One; 2011; 6(7):e21237. PubMed ID: 21779323
[TBL] [Abstract][Full Text] [Related]
13. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
14. The antimalarial drug, chloroquine, interacts with lactate dehydrogenase from Plasmodium falciparum.
Menting JG; Tilley L; Deady LW; Ng K; Simpson RJ; Cowman AF; Foley M
Mol Biochem Parasitol; 1997 Sep; 88(1-2):215-24. PubMed ID: 9274881
[TBL] [Abstract][Full Text] [Related]
15. Sulfonyl-phenyl-ureido benzamidines; a novel structural class of potent antimalarial agents.
Leban J; Pegoraro S; Dormeyer M; Lanzer M; Aschenbrenner A; Kramer B
Bioorg Med Chem Lett; 2004 Apr; 14(8):1979-82. PubMed ID: 15050641
[TBL] [Abstract][Full Text] [Related]
16. Aromatic Surfactant as Aggregating Agent for Aptamer-Gold Nanoparticle-Based Detection of Plasmodium Lactate Dehydrogenase.
Jain P; Chakma B; Singh NK; Patra S; Goswami P
Mol Biotechnol; 2016 Jul; 58(7):497-508. PubMed ID: 27189484
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
Granchi C; Bertini S; Macchia M; Minutolo F
Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
[TBL] [Abstract][Full Text] [Related]
18. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
19. Structure-based drug discovery for Plasmodium falciparum.
Mehlin C
Comb Chem High Throughput Screen; 2005 Feb; 8(1):5-14. PubMed ID: 15720193
[TBL] [Abstract][Full Text] [Related]
20. A model of Plasmodium falciparum lactate dehydrogenase and its implications for the design of improved antimalarials and the enhanced detection of parasitaemia.
Sessions RB; Dewar V; Clarke AR; Holbrook JJ
Protein Eng; 1997 Apr; 10(4):301-6. PubMed ID: 9194154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
